Answers are grounded in this paper and cite their sources.
An inhibitor of microRNA-122 reduces viral load in chimpanzees that are chronically infected with hepatitis C virus, suggesting that such an approach might have therapeutic potential in humans.
No takes yet. Share an insight, caveat, or question.
Roberts et al. (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: